Bortezomib-Induced Superficial Vasculitis in a Kidney Transplant Recipient: A Rare Case

Cureus. 2024 Apr 22;16(4):e58743. doi: 10.7759/cureus.58743. eCollection 2024 Apr.

Abstract

Bortezomib is a frequently administered immunosuppressive agent in kidney transplantation. A 30-year-old male kidney transplant recipient developed an atypical reaction on the left hand in terms of spider-like extensions, indicating erythematous inflammation along the superficial veins after bortezomib intravenous administration. The inflammation spontaneously resolved after three weeks with a bortezomib dose reduction. Nephrologists must be familiar with the potential cutaneous bortezomib-induced adverse effects.

Keywords: antibody-mediated reaction; bortezomib; immunosuppression; kidney transplant; superficial vasculitis.

Publication types

  • Case Reports